CONSOL Energy Inc. (CNX) fell -4.5% during last trading as the stock lost $-0.82 to finish the day at $17.41 with about 5.94M shares changing hands, compared to its three month average trading volume of 4.04M. The $4.1B market cap company, which fluctuated between $17.02 and $18.57 during the day, currently situated 284.01% above its 52 week low of $4.54 and -22.07% away from its one year high of $22.34. The RSI of 33.88 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
CONSOL Energy Inc., together with its subsidiaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers. This division owns rights to extract natural gas in Pennsylvania, West Virginia, and Ohio from approximately 436,000 net Marcellus Shale acres; and controls approximately 119,000 net acres of Utica Shale potential in eastern Ohio, as well as controls 113,000 net acres in Southwestern Pennsylvania and Northern West Virginia that contain the rights to the natural gas in Utica Shale; and owns rights to extract coalbed methane (CBM) in Virginia from approximately 268,000 net CBM acres, which cover a portion of its coal reserves in Central Appalachia. It also owns shallow oil and gas acreage position approximately 825,000 net acres in Illinois, Indiana, Kentucky, West Virginia, Pennsylvania, Virginia, and New York; various acres that have Upper Devonian potential; 116,000 net acres of Chattanooga Shale; and 380,000 net acres of Huron Shale potential in Kentucky, West Virginia, and Virginia, as well as provides midstream gas services. The Coal division engages in mining, preparation, and marketing of thermal coal primarily to power generators, and metallurgical coal to metal and coke producers. The company also provides energy services, including coal terminal services, water services, and land resource management services. CONSOL Energy Inc. was founded in 1864 and is headquartered in Canonsburg, Pennsylvania.
CVS Health Corporation (CVS) gained $1.44 to close the day at a new closing price of $80.35, a 1.82% increase in value from its previous closing price that moved the stock 15.95% above its 52 week low of $69.3. A total of 5.92M shares exchanged hands during the day compared with its three month average trading volume of 8.37M. The stock, which fluctuated between $78.97 and $80.45 during the day, currently situated -23.97% below its 52 week high. The stock is up by 4.68% in the past one month and down by -7.28% over the past three months. With a one year target estimate of $87.1 and RSI of 53.87, the stock still has upside potential, making it a hold for now.
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
MannKind Corporation (MNKD) had a active trading with around 5.91M shares changing hands compared to its three month average trading volume of 4.99M. The stock traded between $0.6 and $0.675 before closing at the price of $0.63 with -0.83% change on the day. The Valencia California 91355 based company is currently trading 54% above its 52 week low of $0.41 and -71.81% below its 52 week high of $2.24. Both the RSI indicator and target price of 51.33 and $0 respectively, lead us to believe that it should be put on hold over the coming weeks.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.